SANDRA ODENHEIMER: Open Payments
NPI 1467528646 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 20 payments from 10 companies in 2025. Trend: 2023 $60 · 2024 $651 · 2025 $755
Food & beverage: $670Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $213 |
| Janssen Biotech, Inc. | 4 | $200 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| ABBVIE INC. | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Incyte Corporation | 2 | $41 |
| PFIZER INC. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
Products named: DUPIXENT, TREMFYA, BOTOX, Zoryve, COSENTYX, OPZELURA, CIBINQO, TALTZ.
Industry payments across CA — which companies pay providers there.
